TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
AEHR

Aehr Test Systems

Technology · Semiconductor Equipment & Materials

107.20$ +5.5% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Balance Sheet

Aehr Test Systems (AEHR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 247 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AEHR
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
11 14 12 31 32 31 32 31 30 30 25 21 22 24 22 21 19 17 19 22 24 58 57 62 62 68 84 98 105 101 102 128 146 142 146 149 144 149 157 247
10 13 11 29 30 30 30 29 28 29 24 20 18 21 18 18 16 14 16 19 22 56 55 60 59 66 77 89 96 92 92 98 93 89 92 89 84 88 96 184
2.3 5.2 2.0 18 14 10.0 9.1 17 16 14 12 5.4 5.3 5.3 5.1 5.4 6.3 3.4 4.7 4.6 6.5 35 32 31 36 19 17 30 51 51 48 49 38 33 30 25 23 31 37 116
2.3 5.2 2.0 18 14 16 15 17 16 14 12 5.4 5.3 5.3 5.1 5.4 6.3 3.4 4.7 4.6 6.5 35 32 31 36 37 43 48 51 51 48 49 38 33 30 25 23 31 37 116
1.8 1.4 1.6 4.0 5.3 3.5 4.7 2.9 2.3 3.9 1.9 4.9 3.3 5.2 3.5 3.7 1.1 1.4 2.7 5.2 4.3 7.4 8.5 13 5.1 10 11 17 13 6.6 5.8 10.0 8.6 7.5 12 18 13 10 12 17
6.0 6.1 7.2 6.6 9.0 8.2 9.4 9.0 9.6 10.0 9.2 9.1 9.2 9.8 9.3 8.0 8.1 9.1 8.3 8.8 10 13 14 15 17 18 22 24 32 34 38 37 43 44 42 42 42 43 41 41
0.8 0.8 0.9 1.4 1.1 1.2 1.2 1.2 1.2 1.1 1.0 1.0 1.0 0.9 0.8 2.8 0.6 0.7 0.6 2.3 2.1 1.9 1.9 2.1 2.1 1.8 7.6 8.9 9.0 – – – 9.8 10 13 19 18 18 18 –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – 0.0 10 11 11 11 11 11 11 11
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – 12 12 11 11 10 10 9.8 9.6
12 10 11 14 14 13 13 12 12 12 10 5.9 6.7 8.3 5.1 6.5 6.4 6.3 8.4 10 9.8 17 13 11 10 11 16 23 25 14 15 16 23 19 21 26 22 18 18 27
6.0 4.2 4.7 7.9 8.1 6.5 6.6 11 11 12 10 5.5 4.5 6.3 3.3 3.9 4.2 4.5 6.9 9.1 8.8 17 13 11 9.9 11 9.4 16 19 8.0 9.2 11 15 12 16 16 12 8.3 8.7 18
– – – 0.1 6.1 6.1 6.1 6.1 6.1 6.1 6.1 0.0 0.6 0.6 0.6 1.3 1.6 1.9 3.6 3.8 0.8 0.8 0.8 0.8 0.7 0.6 0.1 0.1 0.3 0.4 0.4 0.5 0.8 0.9 1.2 0.9 0.9 0.6 0.6 0.6
1.9 1.8 1.8 2.8 3.5 1.8 2.6 1.8 1.3 2.0 0.6 1.9 1.7 2.3 0.9 0.9 0.8 1.2 1.1 2.9 2.8 3.4 3.3 4.2 3.4 3.9 5.0 9.2 8.3 4.2 5.0 5.3 5.6 4.9 7.0 6.7 3.4 3.5 2.1 6.8
6.0 6.1 6.1 6.1 6.1 6.1 6.1 0.0 0.0 0.0 – – – – – 1.0 0.7 0.5 0.2 – – – – – – – – – – – – – – – – – – – – –
-0.7 3.7 1.3 17 17 18 19 19 18 18 15 15 15 16 17 14 12 11 10 11 14 41 44 51 52 57 69 76 80 87 86 112 122 123 124 123 122 131 139 220
-62 -63 -66 -67 -67 -67 -66 -66 -68 -68 -72 -71 -72 -72 -71 -74 -74 -76 -77 -76 -76 -75 -73 -67 -66 -63 -58 -52 -48 -42 -43 -19 -18 -20 -20 -23 -25 -28 -32 -30
13 16 17 23 23 23 23 23 22 22 22 23 23 23 23 23 23 23 24 24 25 28 29 29 29 29 29 30 30 30 29 29 30 30 30 30 30 30 31 31

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?